The people behind the science.

• Benjamin Kelmendi, M.D.

  Director and principal investigator

  Studies

  • Psilocybin for Transdiagnostic Psychiatry Symptoms
  • Repeated Psilocybin Dosing in OCD
  • Psilocybin for Treatment-Resistant OCD — NIMH K23

• Gabby Agin-Liebes

  Study coordinator

  Studies

  • Psilocybin for Transdiagnostic Psychiatry Symptoms

• Gustavo Angarita, M.D.

  Principal investigator

  Studies

  • Synaptotrophic Effects of Psilocybin in Opioid Use Disorder

• Jamila Hokanson, M.D.

  Co-investigator

  Studies

  • Synaptotrophic Effects of Psilocybin in Opioid Use Disorder

• Sophie Holmes, Ph.D.

  Principal investigator

  Studies

  • Psilocybin Therapy for Depression in Parkinson's Disease (PSI-PD)

• Terence Ching, Ph.D.

  Co-investigator

  Studies

  • Repeated Psilocybin Dosing in OCD

We publish a photo or a longer profile only with that person’s permission.

ENACT works with partner institutions and funders too. They are listed under Partners & collaboration.